May 20, 2019

Acute Type A Aortic Dissection Repair: Where to Cannulate?

Large analysis shows initial axillary strategy is feasible, safe, effective

650×450-axillary-cannulation

Systematic use of an initial axillary artery cannulation strategy for emergency repair of acute type A dissection repair is feasible, safe and effective, concludes a retrospective analysis of 775 patients from Cleveland Clinic. The study, published online by the Journal of Thoracic and Cardiovascular Surgery, found that such a strategy can be readily tailored to patients’ individual characteristics and perfusion needs. It further showed that, when used at a high-volume center, this approach results in comparable outcomes regardless of patients’ cannulation site and that outcomes are impacted by patients’ presentation rather than by cannulation site.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Acute aortic dissection is one of the highest-risk emergency operations in cardiovascular surgery, with recent national databases from the U.S. and Germany reporting that one in five patients die after surgery for DeBakey type I or Stanford type A acute dissections.

“Each of the most common cannulation sites for acute type A dissection repair — axillary, femoral and central — offers advantages and drawbacks, and guidelines have been limited by a lack of detail,” says the study’s senior author, cardiothoracic surgeon Lars Svensson, MD, PhD. “Our practice at Cleveland Clinic has evolved into a systematic axillary cannulation approach, with femoral or central cannulation used when axillary access is not ideal or the patient’s presentation argues for another site. We undertook this study to comprehensively review our experience during our shift to this systematic approach and to evaluate patient characteristics and outcomes according to cannulation site.”

Findings on cannulation site trends

He and colleagues reviewed 775 cases of emergency acute type A dissection repair at Cleveland Clinic from January 2000 to January 2017. The site of initial cannulation broke down as follows:

  • 617 axillary (79.6%)
  • 93 femoral (12.0%)
  • 65 central (8.4%)

Reasons for choice of a non-axillary cannulation site were as follows:

  • Unsuitable axillary anatomy in 67 cases (42%)
  • Surgeon preference in 38 cases (24%)
  • Hemodynamic instability in 34 cases (22%)
  • Preexisting cannulation in 19 cases (12%)

The cannulation site was shifted intraoperatively in 82 cases (10.6%). This happened most frequently after initial femoral cannulation (53 of 93 cases; 57.0%), followed by initial central (6 of 65 cases; 9.2%) and initial axillary (23 of 617 cases; 3.7%) cannulation.

Advertisement

Notably, as experience mounted, use of initial axillary cannulation increased, approaching 90% by 2016. This came largely at the expense of femoral cannulation, which declined from approximately half of cases in 2000 to less than 10% by 2016.

Findings on clinical outcomes

In-hospital mortality was 8.6% for the overall cohort and was lowest (7.3%) for the axillary cannulation group, but mortality appeared to be driven predominantly by patients’ presenting condition rather than by cannulation site. On multivariable analysis, the following factors at presentation were significantly associated with mortality: hemodynamic instability, stroke, limb ischemia and aortic regurgitation.

In-hospital stroke occurred in 8.3% of patients in the cohort, with multivariable analysis showing it to be significantly associated with central cannulation and with aortic stenosis. “The association of central cannulation with an increased stroke rate may be related to multiple factors, including intraoperative adjunctive techniques, rather than directly causative,” observes Dr. Svensson, Chair of Cleveland Clinic’s Miller Family Heart & Vascular Institute.

The benefits of flexibility

“Our finding of comparable outcomes among the different cannulation groups suggests that acute outcomes are related chiefly to the underlying disease and its manifestations at presentation and that cannulation site selection has minimal effect on mortality, at least at experienced centers,” Dr. Svensson continues.

He adds that this study breaks new ground by detailing the decision-making process behind cannulation site choice in the context of a systematic approach. “Most prior studies have examined the use of axillary cannulation in elective settings,” he notes. “In contrast, the decision-making that occurs during treatment of acute type A dissection is a highly dynamic process.”

Advertisement

The advantages of axillary cannulation include maintenance of antegrade true lumen blood flow during and after cooling as well as unilateral antegrade brain perfusion during circulatory arrest. Its chief limitation is that it can be time-consuming, but Dr. Svensson points out that it can be done efficiently when performed routinely.

“We estimate that it adds only 15 to 30 minutes to total operative time,” he says. “In hemodynamically unstable patients, a decision has to be made whether to use central or femoral cannulation. This represents a key strength of this overall approach, which encourages tailoring to patients’ individual needs. However, if time permits, axillary cannulation — in cardiac tamponade patients, for example — allows for going onto ‘sucker bypass’ if the aorta ruptures upon opening the chest.”

He adds that this strategy may have contributed to the favorable outcomes reflected in this study, as its 8.6% in-hospital mortality rate compares well with the 12.7% rate recently reported by the International Registry of Acute Aortic Dissections and a range of 7.7% to 17% in published reports from other groups.

This notion is echoed by the authors of an editorial accompanying Dr. Svensson’s study in the Journal of Thoracic and Cardiovascular Surgery. “The authors are to be congratulated…for their excellent surgical outcomes in a large number of patients,” write the editorialists, two cardiac surgeons at the University of Ulsan in Seoul, South Korea. They note that while initial axillary cannulation was a successful “default set” for acute type A dissection repair, the “flexible application of arterial cannulation techniques needs to also be paid attention to…. A ‘plan B’ should always be readily available.”

Related Articles

x-ray of bone fracture in a forearm
March 1, 2024
TRAVERSE Substudy Links Testosterone Therapy to Increased Fracture Risk in Older Men With Hypogonadism

Surprise findings argue for caution about testosterone use in men at risk for fracture

photo of intubated elderly woman in hospital bed
February 23, 2024
Proteomic Study Characterizes Markers of Frailty in Cardiovascular Disease and Their Links to Outcomes

Findings support emphasis on markers of frailty related to, but not dependent on, age

GettyImages-1252287413 [Converted]
September 8, 2023
Black Residents of Historically Redlined Areas Have Increased Heart Failure Risk

Large database study reveals lingering health consequences of decades-old discrimination

23-HVI-4172009 CQD 650×450-2
August 29, 2023
Updates From CLEAR Outcomes and VALOR-HCM: Expanded Benefits With Bempedoic Acid and Mavacamten

Additional analyses of the two trials presented at 2023 ESC Congress

21-HVI-2577809_septal-myectomy-LVOTO-repair_650x450
January 6, 2022
Study Confirms Quality-of-Life Benefits of Myectomy in Obstructive HCM

Prospective SPIRIT-HCM trial demonstrates broad gains over 12-month follow-up

21-HVI-2211308 gender-scales_650x450
August 10, 2021
8 Ways to Increase Women’s Participation in Cardiovascular Trials

An ACC committee issues recommendations to accelerate sluggish progress

20-HVI-1998312_carotid-endarterectomy_650x450
December 4, 2020
Carotid Endarterectomy and the High-Risk Patient

Review of our recent experience shows it’s still a safe option

20-HVI-2006253-artificial-intelligence-heart-research_650x450
November 30, 2020
AI Looms Large in New Studies of Heart Transplant Rejection and Noncompaction Cardiomyopathy

Machine learning may improve risk prediction and guide therapy

Ad